Eimeria

EW Nutrition showcases customer-focused solutions for the animal nutrition industry at VIV Asia 2023

Retrieved on: 
Mittwoch, März 1, 2023
VIV, Growth, Vaccination, Hall, Showtime, Temperature, Eimeria, Pharmaceutical industry, Agriculture

SINGAPORE, March 1, 2023 /PRNewswire/ -- EW Nutrition will participate in VIV Asia 2023 to showcase its newest solutions for the animal nutrition industry.

Key Points: 
  • SINGAPORE, March 1, 2023 /PRNewswire/ -- EW Nutrition will participate in VIV Asia 2023 to showcase its newest solutions for the animal nutrition industry.
  • "We are constantly innovating to provide best-in-class products and programs.
  • Our participation in VIV Asia 2023 is a good opportunity to connect with our partners over EW Nutrition's tailored solutions for industry challenges," says Ramakanta Nayak, regional director for EW Nutrition South East Asia/Pacific.
  • Located at Hall 2, Booth 3550, EW Nutrition's stand highlights flagship products and initiatives, among which:
    Pretect D, a natural solution to mitigate Eimeria-related challenges, making it an effective addition to programs focused on coccidiosis control
    EW Nutrition will also host "Showtime", a series of topical presentations delivered by key industry experts, providing actionable insights into trends and challenges of the animal nutrition industry.

EW Nutrition showcases customer-focused solutions for the animal nutrition industry at VIV Asia 2023

Retrieved on: 
Mittwoch, März 1, 2023
VIV, Growth, Vaccination, Hall, Showtime, Temperature, Eimeria, Pharmaceutical industry, Agriculture

SINGAPORE, March 1, 2023 /PRNewswire/ -- EW Nutrition will participate in VIV Asia 2023 to showcase its newest solutions for the animal nutrition industry.

Key Points: 
  • SINGAPORE, March 1, 2023 /PRNewswire/ -- EW Nutrition will participate in VIV Asia 2023 to showcase its newest solutions for the animal nutrition industry.
  • "We are constantly innovating to provide best-in-class products and programs.
  • Our participation in VIV Asia 2023 is a good opportunity to connect with our partners over EW Nutrition's tailored solutions for industry challenges," says Ramakanta Nayak, regional director for EW Nutrition South East Asia/Pacific.
  • Located at Hall 2, Booth 3550, EW Nutrition's stand highlights flagship products and initiatives, among which:
    Pretect D, a natural solution to mitigate Eimeria-related challenges, making it an effective addition to programs focused on coccidiosis control
    EW Nutrition will also host "Showtime", a series of topical presentations delivered by key industry experts, providing actionable insights into trends and challenges of the animal nutrition industry.

Amlan® International’s Phylox® Honored With 2023 IPPE New Product Showcase “Best of the Best” in Live Production Award

Retrieved on: 
Dienstag, Februar 7, 2023
ODC, Weight gain, Disease, Immunity, Livestock, NYSE, Amlan, Government, Vaccine, Peanut Corporation of America, Southern International Productions, Ionophore, Coccidiosis, Eastman Kodak Co. v. Image Technical Services, Inc., Innovation, Poultry, Mortality, NAE, IPPE, Feed manufacturing, Online shopping, Agriculture, Eimeria

The accolade, awarded at the recent International Production & Processing Expo (IPPE), recognized Amlan for its launch of Phylox, a natural, non-pharmaceutical coccidiosis solution for live production programs including those producers that need to meet the demand for no-antibiotic-ever (NAE) production.

Key Points: 
  • The accolade, awarded at the recent International Production & Processing Expo (IPPE), recognized Amlan for its launch of Phylox, a natural, non-pharmaceutical coccidiosis solution for live production programs including those producers that need to meet the demand for no-antibiotic-ever (NAE) production.
  • Amlan is thankful for the opportunity to share our new product mode-of-action video with the global IPPE audience and we're honored to stand alongside other industry innovators.
  • To view Amlan’s video submission for the “Best of the Best” in Live Production Award on Phylox, please visit https://www.youtube.com/watch?v=c3JwnAuDdSg .
  • Product availability may vary by country; associated claims do not constitute medical claims and may differ based on government requirements.

Amlan International to Showcase Natural Mineral Technology at International Production and Processing Expo (IPPE)

Retrieved on: 
Donnerstag, Januar 12, 2023
Disease, Livestock, NAE, Emerging technologies, Eimeria, NEC Corporation of America, IPPE, IPSF, Coccidiosis, Eastman Kodak Co. v. Image Technical Services, Inc., Government, Sustainability, Leanne, Dir, Poultry, Southern International Productions, Robert B. Hall (Japanologist), NYSE, TV5 Media Center, Effect, Marketing strategy, ODC, Ammonia, Growth, PH, Research, Innovation, Media center, Aquaculture, Feed manufacturing, Agriculture

Last year at IPPE, Amlan expanded its product portfolio with the launch of Phylox (available in select international markets).

Key Points: 
  • Last year at IPPE, Amlan expanded its product portfolio with the launch of Phylox (available in select international markets).
  • Phylox is a research-backed, natural alternative to anticoccidial drugs that supports gut health naturally thus improving productivity and, in turn, driving producers' profits.
  • Vertical integration allows Amlan to leverage Oil-Dri's mineral science expertise to develop novel, natural feed additives.
  • Oil-Dri Corporation of America doing business as “Amlan International” is a publicly traded stock on the New York Stock Exchange (NYSE: ODC).

ZIVO Bioscience CEO Issues Letter to Shareholders

Retrieved on: 
Freitag, September 23, 2022
Health, Infectious Diseases, Agriculture, Natural Resources, Pharmaceutical, Biotechnology, Veterinary, Securities Exchange Act of 1934, Adoption, Health, Gaps, Incidence, Human, Review, Salmonella, CVB, Poultry, Energy Independence and Security Act of 2007, Chicken, Licensure, Farmer, Acquisition, Growth, Intellectual property, USDA, Immunity, Industry, Clostridium perfringens, Achievement, Securities Act of 1933, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, U.S. Securities and Exchange Commission, Letter, Escherichia coli, Nutrient, CEO, Technology, Vaccine, Goal, Coccidiosis, Board of directors, Leadership, Ill, Agtech, List of life sciences, Veterinary biologic, NASDAQ, Biomass, Board, Research, Security (finance), U.S. Department of Agriculture Cotton Annex, Animal, Immune system, Self-affirmation, Disease, Livestock, Management, Fine chemical, Aquaculture, Campylobacter, Eimeria

Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today issued the following letter to shareholders from its Chairman, President and Chief Executive Officer, John Payne.

Key Points: 
  • Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today issued the following letter to shareholders from its Chairman, President and Chief Executive Officer, John Payne.
  • Through establishing partnerships and scaling our manufacturing capacity, ZIVO is undergoing a transformation aimed at maximizing the value of our product portfolio for our customers, partners, and shareholders.
  • Through this letter Id like to provide an overview of why others find our product candidates to be so attractive.
  • On behalf of the ZIVO team, as well as our Board of Directors, I want to thank our shareholders for their continued support.

Amlan International Launches Two New Natural Alternatives to Antibiotics for Poultry and Livestock

Retrieved on: 
Mittwoch, April 27, 2022
Diarrhea, Solution, Biological life cycle, Marketing, NYSE, Program, Vaccine, Poultry, Peanut Corporation of America, Sale, Organic acid, Economics, Journal, Coccidiosis, GLOBE, Research, Incidence, Livestock, Efficiency, UC, VP, Immunity, Animal, ODC, Animal nutritionist, Veterinarian, Fungus, Degenerative disease, New, Science, Feed, Journal of Animal Science, Rotation, Government, University of California, Davis, Escherichia coli, Health, Disease, Toxin (comics), Aquaculture, Pig, Feed manufacturing, Dietary supplement, Eimeria

To help producers recapture this protection, Amlan International, the animal health business of Oil-Dri Corporation of America, has launched two new natural products Phylox Feed and NeutraPath that help optimize intestinal health and production economics in the absence of antibiotics.

Key Points: 
  • To help producers recapture this protection, Amlan International, the animal health business of Oil-Dri Corporation of America, has launched two new natural products Phylox Feed and NeutraPath that help optimize intestinal health and production economics in the absence of antibiotics.
  • Phylox Feed is a natural alternative to anticoccidial drugs and vaccines that can help producers increase profitability.
  • Coccidiosis, caused by Eimeria species, is an enteric disease that can have a significant economic impact on animal protein production.
  • Oil-Dri Corporation of America doing business as Amlan International is a publicly traded stock on the New York Stock Exchange (NYSE: ODC).

Amlan to Feature New Product, Phylox® and Share Recent Commercial Varium® Research at XLVI ANECA 2022 Annual Congress

Retrieved on: 
Dienstag, März 15, 2022
Program, Solution, Clostridium perfringens, UNAM, GLOBE, Ionophore, Health, ODC, National Association, XLVI, Government, Clostridial necrotizing enteritis, Transport, ANECA, Economics, Poultry, Marketing, Research, Congress, Bird, NYSE, Industry, Poultry Science Association, Salmonella, Culture, New, VP, Feed manufacturing, Coccidiosis, Eimeria

The active ingredients in Phylox have been demonstrated through independent research to interrupt the life cycle of various Eimeria species, the causative agents in coccidiosis.

Key Points: 
  • The active ingredients in Phylox have been demonstrated through independent research to interrupt the life cycle of various Eimeria species, the causative agents in coccidiosis.
  • The synergistic blend of bioactive phytochemicals in Phylox also helps strengthen bird intestinal integrity and supports strong, natural immune function.
  • Amlan is taking part in multiple events throughout the ANECA congress including hosting a presentation at 9 a.m. on Thursday, March 31, byDr.
  • Further details about the XLVI ANECA 2022 Annual Congress can be found here .

Amlan International to Present New Research During International Production and Processing Expo (IPPE)

Retrieved on: 
Donnerstag, Januar 13, 2022
Research, DVM, National university, Flora (microbiology), NYSE, Homeostasis, IPPE, Efficiency, Marketing, Laboratory, Technology, Universidad, Southern International Productions, Congress Center, Wall, IPSF, Doctor of Philosophy, Poultry, Poultry Science Association, Health, Master of Science, TTSS, ODC, Mycotoxin, Livestock, III, Mallmann, 2021 Essex County Council election, Georgia World Congress Center, Government, University of Arkansas, GLOBE, M52, Miniature pig, University, Feed manufacturing, International, Eimeria, Microbiology

IPPE attendees will be able to hear about Amlan technology, interact with Amlan experts, and even hold Amlans mineral in their hands at booth B5255.

Key Points: 
  • IPPE attendees will be able to hear about Amlan technology, interact with Amlan experts, and even hold Amlans mineral in their hands at booth B5255.
  • The global Amlan team invites IPPE attendees to learn more about the Amlan difference in bringing innovative solutions to improve the welfare and sustainability of food production while also ensuring optimum production efficiency.
  • During Almans educational TECHTalk presentations, renowned poultry industry experts will share new information on tackling poultry industry challenges.
  • Oil-DriCorporation of America doing business as Amlan International is a publiclytraded stock on the New York StockExchange (NYSE: ODC).

Kemin Industries Partners with Pacific GeneTech to Launch First Inactivated Eimeria Vaccine to Global Poultry Industry

Retrieved on: 
Donnerstag, Oktober 15, 2020
Conoidasida, Kemin Industries, Medical specialties, Eimeria, Kemin, Vaccine, Medicine, Veterinary medicine

We are thrilled to be working side-by-side with them to bring innovative solutions to market that are needed in the animal health industry."

Key Points: 
  • We are thrilled to be working side-by-side with them to bring innovative solutions to market that are needed in the animal health industry."
  • As part of its partnership with PGT, Kemin will focus on developing the Eimeria vaccine and registering it in the U.S., and other countries beginning with the European Union.
  • Kemin will also expand the Eimeria vaccine's availability to Asia, the Middle East, Africa and Latin America.
  • TM Trademarks of Kemin Industries, Inc., U.S.A.
    Certain statements, product labeling and claims may differ by geography or as required by government requirements.

Kemin Launches VANNIX™ C4 for Poultry Producers in the United States

Retrieved on: 
Donnerstag, Januar 16, 2020
Livestock, Phytogenics, Clostridium perfringens, Eimeria, Feed additive, Additive, Organisms, Primary industries, Industries, Delacon

VANNIX C4 is a proprietary formulation of natural, gut-health-fortifying ingredients designed as a cost-effective solution for producers to minimize the impact of enteric challenges on poultry performance.

Key Points: 
  • VANNIX C4 is a proprietary formulation of natural, gut-health-fortifying ingredients designed as a cost-effective solution for producers to minimize the impact of enteric challenges on poultry performance.
  • Independently published research has shown that select phytogenic molecules can reduce the impact of enteritic pathogens such as Eimeria and Clostridium perfringens on poultry performance.
  • "As a novel phytogenic feed additive, VANNIX C4 offers producers a new tool to support and rotate into gut health management programs, helping to promote performance and preserve the efficacy of current products."
  • VANNIX C4 differs from conventional phytogenic feed additives on the market today:
    VANNIX C4 joins the existing line of "Knock Out" solutions in the Kemin Gut Health Triple Check : CLOSTAT, CLOSTAT WS and KEM SAN.